Form 4 for EW Edwards Lifesciences
Accepted 2021-11-29 00:00:00 ET · period of report 2021-11-29 · accession 0001225208-21-014184 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-29 | 2021-11-29 | EW | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer | S - Sale+OE | $110.58 | -100 | 152.1K | -0.1% | -$11.1K |
| D | 2021-11-29 | 2021-11-29 | EW | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer | M - OptEx | $21.76 | +100 | 152.2K | +0.1% | +$2,176 |
| D | 2021-11-29 | 2021-11-29 | EW | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer | M - OptEx | $0.00 | -100 | 34.9K | -0.3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-29 | S | D | 100 | $110.58 | 152,103.49 | D | — | — | |
| 2 | Common | Common Stock | 2021-11-29 | M | A | 100 | $21.76 | 152,203.49 | D | — | — | |
| 3 | Derivative | Employee Stock Option (Right to Acquire) | 2021-11-29 | M | D | 100 | $0.00 | 34,880 | D | $21.76 · 2016-05-14 to 2022-05-13 | 100 Common Stock |